Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 30

1.

Significance of histological response to preoperative chemoradiotherapy for pancreatic cancer.

White RR, Xie HB, Gottfried MR, Czito BG, Hurwitz HI, Morse MA, Blobe GC, Paulson EK, Baillie J, Branch MS, Jowell PS, Clary BM, Pappas TN, Tyler DS.

Ann Surg Oncol. 2005 Mar;12(3):214-21. Epub 2005 Mar 3.

PMID:
15827813
2.

Review of adjuvant radiochemotherapy for resected pancreatic cancer and results from Mayo Clinic for the 5th JUCTS symposium.

Miller RC, Iott MJ, Corsini MM.

Int J Radiat Oncol Biol Phys. 2009 Oct 1;75(2):364-8. doi: 10.1016/j.ijrobp.2008.11.069. Review.

PMID:
19735864
3.

[Histologic response after neoadjuvant therapy in rectal adenocarcinoma: own experience and review of the literature].

Mátrai Z, Lövey J, Hitre E, Orosz Z, Gödény M, Péley G, Sulyok Z, Rényi Vámos F, Farkas E, Köves I.

Orv Hetil. 2006 Oct 22;147(42):2011-20. Review. Hungarian.

PMID:
17165600
4.

[Concomitant chemoradiotherapy and preoperative radiotherapy in exocrine pancreatic adenocarcinoma].

Mornex F, Gérard JP, Chauffert B, Brun M.

Ann Chir. 2000 Feb;125(2):111-7. Review. French.

PMID:
10998795
5.

Radiochemotherapy in the management of pancreatic cancer--part I: neoadjuvant treatment.

Mornex F, Girard N, Delpero JR, Partensky C.

Semin Radiat Oncol. 2005 Oct;15(4):226-34. Review.

PMID:
16183476
6.

Complete response to neoadjuvant chemoradiotherapy in esophageal carcinoma is associated with significantly improved survival.

Berger AC, Farma J, Scott WJ, Freedman G, Weiner L, Cheng JD, Wang H, Goldberg M.

J Clin Oncol. 2005 Jul 1;23(19):4330-7. Epub 2005 Mar 21. Review.

PMID:
15781882
7.

Is there a role for chemoradiotherapy in the treatment of pancreatic carcinoma?

Pasetto LM, Jirillo A, Stefani M, Monfardini S.

Anticancer Res. 2003 May-Jun;23(3C):2805-13. Review.

PMID:
12926117
8.

Preoperative chemoradiation in resectable pancreatic cancer.

Chandler NM, Canete JJ, Stuart KE, Callery MP.

J Hepatobiliary Pancreat Surg. 2003;10(1):61-6. Review.

PMID:
12918459
9.

[Concomitant chemoradiotherapy in the therapeutic strategy of adenocarcinoma of the exocrine pancreas and stomach].

Mornex F, Chauffert B.

Cancer Radiother. 1998 Dec;2(6):696-702. Review. French.

PMID:
9922775
10.

[Adjuvant and neoadjuvant treatment for pancreatic adenocarcinoma in 2006].

Deberne M, Huguet F, Le Scodan R, Hammel P, Andre T.

Bull Cancer. 2007 Jan;94(1):72-80. Review. French.

11.

Neoadjuvant therapy for pancreatic cancer: the Duke experience.

White RR, Tyler DS.

Surg Oncol Clin N Am. 2004 Oct;13(4):675-84, ix-x. Review.

PMID:
15350941
12.

Adenocarcinoma of the pancreas: the rationale for neoadjuvant therapy.

Sperti C, Pasquali C, Pastorelli D, Ferronato A, Decet G, Pedrazzoli S.

Acta Biomed. 2003;74 Suppl 2:91-5. Review.

PMID:
15055044
13.
14.

Adjuvant therapy following resection for pancreatic adenocarcinoma.

Brennan MF.

Surg Oncol Clin N Am. 2004 Oct;13(4):555-66, vii. Review.

PMID:
15350934
15.

Neoadjuvant therapy for resectable pancreatic cancer.

Raut CP, Evans DB, Crane CH, Pisters PW, Wolff RA.

Surg Oncol Clin N Am. 2004 Oct;13(4):639-61, ix. Review.

PMID:
15350939
16.

Preoperative chemoradiation therapy for adenocarcinoma of the pancreas: The Fox Chase Cancer Center experience, 1986-2003.

Meszoely IM, Wang H, Hoffman JP.

Surg Oncol Clin N Am. 2004 Oct;13(4):685-96, x. Review.

PMID:
15350942
17.

Evolving strategies for the treatment of adenocarcinoma of the pancreas. A review.

Ettinghausen SE, Schwartzentruber DJ, Sindelar WF.

J Clin Gastroenterol. 1995 Jul;21(1):48-60. Review.

PMID:
7560834
18.
19.

Should adjuvant therapy remain the standard of care for patients with resected adenocarcinoma of the pancreas?

Chu QD, Khushalani N, Javle MM, Douglass HO Jr, Gibbs JF.

Ann Surg Oncol. 2003 Jun;10(5):539-45. Review.

PMID:
12794020
20.

[Pancreatic cancer: what is new in 2005?].

Hammel P.

Bull Cancer. 2006 Jan;93(1):67-72. Review. French.

Supplemental Content

Support Center